This is a Validated Antibody Database (VAD) review about human KRT15, based on 173 published articles (read how Labome selects the articles), using KRT15 antibody in all methods. It is aimed to help Labome visitors find the most suited KRT15 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
KRT15 synonym: CK15; K15; K1CO

Invitrogen
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 6b
Invitrogen KRT15 antibody (eBioscience, 53-9003-82) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 6b). Commun Biol (2022) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig 2, 4a, 4b
Invitrogen KRT15 antibody (InVitrogen, MA5-13156) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 2, 4a, 4b). Mol Oncol (2022) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 2b
Invitrogen KRT15 antibody (Lab Vision, MS-343-P) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 2b). Sci Adv (2021) ncbi
mouse monoclonal (AE1/AE3)
  • flow cytometry; human; loading ...
Invitrogen KRT15 antibody (eBioscience, 53-9003-82) was used in flow cytometry on human samples . Nat Commun (2021) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4a
Invitrogen KRT15 antibody (eBioscience, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples (fig 4a). Proc Natl Acad Sci U S A (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; rhesus macaque; 0.2 ug/ml; loading ...; fig 4g
Invitrogen KRT15 antibody (Thermo Fisher, 41-9003-82) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 0.2 ug/ml (fig 4g). Science (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 1a
Invitrogen KRT15 antibody (eBioscience, 53-9003-80) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1a). Nat Cell Biol (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; fig 4, 5
Invitrogen KRT15 antibody (eBioscience, AE1/AE3) was used in immunocytochemistry on human samples (fig 4, 5). Breast Cancer Res (2019) ncbi
mouse monoclonal (LHK15)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 8a
Invitrogen KRT15 antibody (ThermoFisher, LHK15) was used in immunohistochemistry - paraffin section on mouse samples (fig 8a). Invest Ophthalmol Vis Sci (2017) ncbi
mouse monoclonal (PAN-CK)
  • immunocytochemistry; human; loading ...; fig s1b
In order to study the suppressive effect of DNAJB6 and Hsp70 on alpha-synuclein aggregation, Invitrogen KRT15 antibody (Thermo Fischer, MA5-13203) was used in immunocytochemistry on human samples (fig s1b). Sci Rep (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:150; loading ...; tbl 2
In order to describe the differences between Xp11 translocation renal cell carcinoma and the corresponding mesenchymal neoplasm, Invitrogen KRT15 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:150 (tbl 2). Hum Pathol (2017) ncbi
mouse monoclonal (LHK15)
  • immunohistochemistry; dogs; 1:50; fig 5d,6d,7d,8d
In order to characterize an atypical cutaneous tumor of a 9-year-old mixed breed female dog, Invitrogen KRT15 antibody (Thermo, LHK15) was used in immunohistochemistry on dogs samples at 1:50 (fig 5d,6d,7d,8d). J Vet Med Sci (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; loading ...; fig 3d
In order to discuss a case of mixed adenoneuroendocrine carcinoma of stomach with tubular adenoma and well-differentiated neuroendocrine tumor in the primary tumor in the stomach, Invitrogen KRT15 antibody (Thermo Scientific, AE1-AE3) was used in immunohistochemistry on human samples (fig 3d). Case Rep Pathol (2016) ncbi
mouse monoclonal (LHK15)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 2c
In order to use photodynamic therapy to remove nonpigmented hair, Invitrogen KRT15 antibody (Thermo Fisher Scientific, LHK15) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 2c). Lasers Surg Med (2016) ncbi
mouse monoclonal (PAN-CK)
  • immunocytochemistry; mouse; loading ...; fig 3c
  • western blot; mouse; loading ...; fig 3d
In order to identify keratin-associated protein 5-5 as a driver of endothelial monolayer invasion, Invitrogen KRT15 antibody (Thermo Scientific, MA5-13203) was used in immunocytochemistry on mouse samples (fig 3c) and in western blot on mouse samples (fig 3d). Oncogene (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 5b
In order to investigate inflammatory responses present at the breast cancer biopsy wound site, Invitrogen KRT15 antibody (Thermo Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples (fig 5b). Breast Cancer Res Treat (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; 1:50; fig 1
In order to analyze the induction of apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue by cisplatin and doxorubicin, Invitrogen KRT15 antibody (ThermoFisher Scientific, MA5-13156) was used in immunocytochemistry on human samples at 1:50 (fig 1). Future Oncol (2016) ncbi
mouse monoclonal (LHK15)
  • immunocytochemistry; human; 1:200; loading ...; fig 3c
In order to optimize conditions to generate human pluripotent stem cell-derived limbal epithelial stem cells, Invitrogen KRT15 antibody (Thermo Scientific, MS-1068-P1) was used in immunocytochemistry on human samples at 1:200 (fig 3c). Exp Eye Res (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; fig s3
In order to test if the operating room environment contains human skin bacteria that could be seeding C-section born infants, Invitrogen KRT15 antibody (Molecular Probes, 985542A) was used in immunohistochemistry - paraffin section on human samples (fig s3). Microbiome (2015) ncbi
mouse monoclonal (PAN-CK)
  • immunohistochemistry - paraffin section; mouse; fig 4
In order to describe functionally enriched ES cell transgenics, Invitrogen KRT15 antibody (Thermo Scientific, MA5-13203) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). Sci Rep (2015) ncbi
mouse monoclonal (LHK15)
  • immunocytochemistry; human; 1:25; fig 2a
In order to analyze propagation of oestrogen-responsive and oestrogen receptor-positive normal human breast cells in culture, Invitrogen KRT15 antibody (NeoMarkers, MS-1068-P) was used in immunocytochemistry on human samples at 1:25 (fig 2a). Nat Commun (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:50; fig 3
In order to determine the desmoplastic interface in xenograft tumor in mice comprised of stromal and endothelial cells, Invitrogen KRT15 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3). Pathol Res Pract (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; mouse; 1:100; loading ...; tbl 2
In order to investigate if conditioned medium from proliferating fibroblasts induce a subset of hematopoietic cells to become adherent fibroblast-like cells, Invitrogen KRT15 antibody (eBioscience, 41-9003) was used in immunocytochemistry on mouse samples at 1:100 (tbl 2). J Cell Physiol (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; tbl 2
In order to study a northern New England hospital and increased utilization, verification, and clinical implications of immunocytochemistry, Invitrogen KRT15 antibody (Thermo Scientific, AE1/AE3) was used in immunohistochemistry on human samples (tbl 2). Diagn Cytopathol (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; carp
In order to establish and characterize a new cell line generated from the caudal fin tissue of ornamental common carp, Invitrogen KRT15 antibody (Life Technologies, MA5-13156) was used in immunocytochemistry on carp samples . In Vitro Cell Dev Biol Anim (2015) ncbi
mouse monoclonal (AE1/AE3)
  • flow cytometry; human
  • immunocytochemistry; human; 1 ul
Invitrogen KRT15 antibody (eBioscience, 53-9003-82) was used in flow cytometry on human samples and in immunocytochemistry on human samples at 1 ul. Nanomedicine (2015) ncbi
mouse monoclonal (C11)
  • western blot; human; 1:1000
In order to develop an immunofluorescence method to assess MCT1 and MCT4 in circulating tumor cells and as them as biomarkers of AZD3965 in cancer patients, Invitrogen KRT15 antibody (Thermo Scientific, 4545) was used in western blot on human samples at 1:1000. BMC Cancer (2015) ncbi
mouse monoclonal (PAN-CK)
  • western blot; human
In order to study the impact of TNF-alpha and IL-1beta on the inflammatory phenotype of cancer-associated fibroblasts and mesenchymal stem/stromal cells, Invitrogen KRT15 antibody (Thermo Fisher Scientific, MA5-13203) was used in western blot on human samples . Stem Cell Res Ther (2015) ncbi
mouse monoclonal (AE1/AE3)
In order to generate and characterize a thymic cell line derived from Channa striatus, Invitrogen KRT15 antibody (Invitrogen, AE1/AE3) was used . In Vitro Cell Dev Biol Anim (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 10-20 ug/ml
In order to identify biomarkers for nasopharyngeal carcinoma, Invitrogen KRT15 antibody (Lab.Vision, Ab-1) was used in immunohistochemistry - paraffin section on human samples at 10-20 ug/ml. Asian Pac J Cancer Prev (2015) ncbi
mouse monoclonal (AE1)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig s6
In order to study how redox-dependent senescence is induced by fumarate to modify glutathione metabolism, Invitrogen KRT15 antibody (Thermo, MS-34) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6). Nat Commun (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig s6
In order to study how redox-dependent senescence is induced by fumarate to modify glutathione metabolism, Invitrogen KRT15 antibody (Thermo, MS-34) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6). Nat Commun (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 5
In order to determine the link between cell cycle control and proliferative potential of epidermal progenitor cells by the carboxy-terminus of p63, Invitrogen KRT15 antibody (ThermoFisher Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 5). Development (2015) ncbi
mouse monoclonal (AE1)
  • immunohistochemistry; human; ready-to-use
In order to describe a tumor from a patient with oncocytic cystadenoma, Invitrogen KRT15 antibody (Thermo Scientific, AE1) was used in immunohistochemistry on human samples at ready-to-use. Medicine (Baltimore) (2014) ncbi
mouse monoclonal (AE-1)
  • immunohistochemistry; human; ready-to-use
In order to describe a tumor from a patient with oncocytic cystadenoma, Invitrogen KRT15 antibody (Thermo Scientific, AE1) was used in immunohistochemistry on human samples at ready-to-use. Medicine (Baltimore) (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
In order to assess the prognostic value of immunohistochemical markers in nonhuman primates, Invitrogen KRT15 antibody (Neo Markers, MS343) was used in immunohistochemistry - paraffin section on human samples at 1:100. Comp Med (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200; fig 3
In order to study juxtacrine signaling from macrophages and monocytes and a breast cancer stem cell niche, Invitrogen KRT15 antibody (eBioscience, 53-9003-80) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3). Nat Cell Biol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen KRT15 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Hum Pathol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen KRT15 antibody (Thermo Fisher Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Rom J Morphol Embryol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human
In order to determine the role of myofibroblasts in salivary gland adenoid cystic carcinoma invasiveness, Invitrogen KRT15 antibody (Invitrogen, AE1/AE3) was used in immunocytochemistry on human samples . Histopathology (2015) ncbi
mouse monoclonal (LHK15)
In order to study the role of heparan sulfate in hair follicle and sebaceous gland morphogenesis and homeostasis, Invitrogen KRT15 antibody (Thermo Scientific, MS-1068) was used . J Biol Chem (2014) ncbi
mouse monoclonal (6E7)
  • western blot; human; 1:1000
In order to investigate the TGFBR3-JUND-KRT5 regulatory circuit that is time and matrix-dependent in single breast epithelial cells and basal-like premalignancies, Invitrogen KRT15 antibody (Thermo, MA5-15567) was used in western blot on human samples at 1:1000. Nat Cell Biol (2014) ncbi
mouse monoclonal (LHK15)
  • immunocytochemistry; human; 1:25
  • immunohistochemistry; human; 1:25
In order to investigate the role of CEACAM6 in luminal, HER2-enriched, and basal-like breast cancers, Invitrogen KRT15 antibody (NeoMarkers, LHK15) was used in immunocytochemistry on human samples at 1:25 and in immunohistochemistry on human samples at 1:25. Am J Pathol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human
In order to test if computed tomography-lymphography distinguishes sentinel nodes from non-sentinel nodes in patients with breast cancer, Invitrogen KRT15 antibody (Thermo, AE1/AE3) was used in immunohistochemistry on human samples . BMC Med Imaging (2013) ncbi
mouse monoclonal (LHK15)
  • immunohistochemistry; mouse; 1:100; fig 3
In order to determine how label retaining cells (LRCs) with myoepithelial characteristic from the proximal acinar region create stem cells in the sweat gland, Invitrogen KRT15 antibody (Thermo Scientific, MS-1068-P1) was used in immunohistochemistry on mouse samples at 1:100 (fig 3). PLoS ONE (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human
Invitrogen KRT15 antibody (Thermo Fisher, AE1/AE3) was used in immunocytochemistry on human samples . Biomed Mater (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human
In order to determine the predictive criteria of the size of nodal metastases with superparamagnetic iron oxide-enhanced MR imaging in breast cancer, Invitrogen KRT15 antibody (Thermoelectron, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples . BMC Med Imaging (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to report the clinicopathological features of 9 breast malignant fibrous histiocytoma patients, Invitrogen KRT15 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Sci Rep (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; 1:100; fig 1
Invitrogen KRT15 antibody (eBioscience, AE1/AE3) was used in immunocytochemistry on human samples at 1:100 (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; tbl 1
In order to characterize a case of malignant ossifying fibromyxoid tumor in the tongue, Invitrogen KRT15 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry on human samples (tbl 1). Head Face Med (2013) ncbi
mouse monoclonal (LHK15)
  • immunohistochemistry; mouse
In order to study the effects of conditional epidermal knockout of HDAC-1 and -2 on murine ectodermal organ morphogenesis, Invitrogen KRT15 antibody (Lab Vision, MS-1068) was used in immunohistochemistry on mouse samples . J Invest Dermatol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 1:200; fig 4
In order to present the third case of thymoma and the second invasive thymoma to metastasize to the cavernous sinus and adjacent to the pituitary, Invitrogen KRT15 antibody (Zymed, AE1-AE3) was used in immunohistochemistry on human samples at 1:200 (fig 4). Surg Neurol Int (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; fig 2
In order to present a case of not otherwise specified-type sarcoma with CD10 expression in the left breast, Invitrogen KRT15 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry on human samples (fig 2). Diagn Pathol (2013) ncbi
mouse monoclonal (LHK15)
In order to investigate the role of Notch signaling in the maintenance of conjunctival epithelial identity, Invitrogen KRT15 antibody (Thermo Scientific, MS-1068) was used . Development (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; Atlantic salmon; 1:50; fig 2
In order to study cell tropism of infectious salmon anemia virus, Invitrogen KRT15 antibody (Invitrogen, AE1/AE3) was used in immunocytochemistry on Atlantic salmon samples at 1:50 (fig 2). Virol J (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
In order to review features of choroid plexus carcinoma, Invitrogen KRT15 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Med Sci Monit (2012) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse
In order to investigate the positioning of taste buds in circumvallate papilla and branching morphogenesis of von Ebners' gland in tongue development, Invitrogen KRT15 antibody (Thermo Scientific, MS-343) was used in immunohistochemistry - paraffin section on mouse samples . Anat Cell Biol (2011) ncbi
mouse monoclonal (C-11)
  • immunohistochemistry - paraffin section; human; 1:100
  • immunocytochemistry; human; 1:100
In order to investigate epithelial to mesenchymal transition during metastasis of pancreatic cancer, Invitrogen KRT15 antibody (Labvision, MS-149) was used in immunohistochemistry - paraffin section on human samples at 1:100 and in immunocytochemistry on human samples at 1:100. Br J Cancer (2012) ncbi
mouse monoclonal (LHK15)
  • immunohistochemistry; human; 1:150; tbl 3
In order to measure the rate of concurrent ocular surface diseases in patients with pterygia, Invitrogen KRT15 antibody (Thermo Fisher Scientific, LHK15) was used in immunohistochemistry on human samples at 1:150 (tbl 3). Am J Pathol (2011) ncbi
mouse monoclonal (LHK15)
  • immunohistochemistry; human; fig 2
In order to study the expression pattern of stem cells in the bulbar conjunctival epithelium, Invitrogen KRT15 antibody (Lab Vision, LHK15) was used in immunohistochemistry on human samples (fig 2). J Cell Physiol (2010) ncbi
mouse monoclonal (AE-1)
  • immunohistochemistry - paraffin section; human; 1:300; tbl 2
In order to characterize feline endometrial adenocarcinomas immunohistochemically, Invitrogen KRT15 antibody (Zymed, AE1) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl 2). J Comp Pathol (2009) ncbi
mouse monoclonal (AE1)
  • immunohistochemistry - paraffin section; human; 1:300; tbl 2
In order to characterize feline endometrial adenocarcinomas immunohistochemically, Invitrogen KRT15 antibody (Zymed, AE1) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl 2). J Comp Pathol (2009) ncbi
mouse monoclonal (C-11)
  • western blot; mouse
In order to develop and characterize a murine model to study enterotoxigenic Bacteroides fragilis infection, Invitrogen KRT15 antibody (Invitrogen, C-11) was used in western blot on mouse samples . Infect Immun (2009) ncbi
mouse monoclonal (C11)
  • western blot; mouse
In order to develop and characterize a murine model to study enterotoxigenic Bacteroides fragilis infection, Invitrogen KRT15 antibody (Invitrogen, C-11) was used in western blot on mouse samples . Infect Immun (2009) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200
In order to discuss the morphological diversity of glioblastomas, Invitrogen KRT15 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:200. Cancer (2008) ncbi
mouse monoclonal (AE1/AE3)
  • western blot; human; fig 5
In order to investigate the effect of COX-2 overexpression on inhibiting proliferation, apoptosis and differentiation, Invitrogen KRT15 antibody (Lab Vision, MS-343-P) was used in western blot on human samples (fig 5). Int J Cancer (2005) ncbi
mouse monoclonal (C11)
  • western blot; mouse
In order to study the role of keratins in modulating cFlip and ERK1/2 apoptotic signaling in epithelial cells, Invitrogen KRT15 antibody (NeoMarkers, C-11) was used in western blot on mouse samples . Mol Cell Biol (2004) ncbi
mouse monoclonal (C-11)
  • western blot; mouse
In order to study the role of keratins in modulating cFlip and ERK1/2 apoptotic signaling in epithelial cells, Invitrogen KRT15 antibody (NeoMarkers, C-11) was used in western blot on mouse samples . Mol Cell Biol (2004) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:80; tbl 1
In order to describe four cases of oncocytic adrenocortical carcinomas, Invitrogen KRT15 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:80 (tbl 1). Pathol Int (2004) ncbi
mouse monoclonal (AE1/AE3)
  • western blot; human; 1:1000; fig 2
In order to study how cell-matrix interactions influence the invasive behavior of a novel, primary peritoneal carcinosarcoma cell line, Invitrogen KRT15 antibody (Zymed, AE1/AE3) was used in western blot on human samples at 1:1000 (fig 2). Gynecol Oncol (2003) ncbi
Abcam
domestic rabbit monoclonal (EPR1614Y)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1c
Abcam KRT15 antibody (Abcam, EPR1614Y) was used in immunohistochemistry - frozen section on mouse samples (fig 1c). Stem Cell Res Ther (2022) ncbi
mouse monoclonal (LHK15)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 3f
Abcam KRT15 antibody (Abcam, ab80522) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 3f). Br J Pharmacol (2021) ncbi
mouse monoclonal (LHK15)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2d
Abcam KRT15 antibody (Abcam, ab80522) was used in immunohistochemistry - paraffin section on mouse samples (fig 2d). Theranostics (2020) ncbi
mouse monoclonal (LHK15)
  • immunohistochemistry - frozen section; human; 1:1000; loading ...; fig 1b
Abcam KRT15 antibody (Abcam, ab80522) was used in immunohistochemistry - frozen section on human samples at 1:1000 (fig 1b). Aging Cell (2020) ncbi
mouse monoclonal (LHK15)
  • immunocytochemistry; human; 1:200; loading ...; fig 2c
Abcam KRT15 antibody (Abcam, ab80522) was used in immunocytochemistry on human samples at 1:200 (fig 2c). Stem Cell Res Ther (2019) ncbi
mouse monoclonal (LHK15)
  • western blot; human; loading ...; fig 3c
Abcam KRT15 antibody (Abcam, ab80522) was used in western blot on human samples (fig 3c). Sci Rep (2019) ncbi
mouse monoclonal (LHK15)
  • immunohistochemistry; human; 1:1000; fig 6
In order to examine TGFBR1 and TGFBR2 mutations in human vemurafenib-induced skin lesions and in sporadic cutaneous squamous cell carcinoma, Abcam KRT15 antibody (Abcam, 80522) was used in immunohistochemistry on human samples at 1:1000 (fig 6). Nat Commun (2016) ncbi
mouse monoclonal (LHK15)
  • immunohistochemistry - frozen section; mouse; fig 4
In order to describe a role for Nbn in skin homeostasis, Abcam KRT15 antibody (Abcam, ab80522) was used in immunohistochemistry - frozen section on mouse samples (fig 4). Oncotarget (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (SPM190)
  • immunohistochemistry - paraffin section; mouse; fig 5
In order to elucidate inhibition of BCL-W and BCL-XL by directed elimination of senescent cells, Santa Cruz Biotechnology KRT15 antibody (santa Cruz, sc-56520) was used in immunohistochemistry - paraffin section on mouse samples (fig 5). Nat Commun (2016) ncbi
mouse monoclonal (LHK15)
  • immunocytochemistry; human; fig 4
Santa Cruz Biotechnology KRT15 antibody (santa Cruz, sc-47697) was used in immunocytochemistry on human samples (fig 4). Mol Vis (2015) ncbi
mouse monoclonal (LHK15)
  • immunohistochemistry; human; 1:20; fig 6
In order to characterize human diabetic organ-cultured corneas by targeting miR-146a to treat delayed wound healing, Santa Cruz Biotechnology KRT15 antibody (anta Cruz Biotechnology, sc-47697) was used in immunohistochemistry on human samples at 1:20 (fig 6). PLoS ONE (2014) ncbi
mouse monoclonal (LHK15)
  • immunohistochemistry - frozen section; human; 1:10
In order to evaluate the therapeutical effects of gene therapy of limbal cells, Santa Cruz Biotechnology KRT15 antibody (Santa Cruz biotechnology, sc-47697) was used in immunohistochemistry - frozen section on human samples at 1:10. Exp Eye Res (2014) ncbi
mouse monoclonal (SPM190)
  • immunohistochemistry; human; fig 1
In order to study the role of human eccrine sweat gland cells during epidermal regeneration, Santa Cruz Biotechnology KRT15 antibody (Santa Cruz, spm190) was used in immunohistochemistry on human samples (fig 1). J Invest Dermatol (2014) ncbi
Novus Biologicals
domestic rabbit monoclonal (ST04-85)
  • immunohistochemistry; human; loading ...; fig 1a
Novus Biologicals KRT15 antibody (Novus, NBP2-67525) was used in immunohistochemistry on human samples (fig 1a). Cell Stem Cell (2021) ncbi
OriGene
mouse monoclonal (6E7)
  • immunocytochemistry; human; 1:1000; loading ...; fig 1d
OriGene KRT15 antibody (OriGene Technologies, AM06387SU-N) was used in immunocytochemistry on human samples at 1:1000 (fig 1d). Exp Ther Med (2021) ncbi
BioLegend
chicken polyclonal (Poly18339)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 4
BioLegend KRT15 antibody (Biolegend, 833904) was used in immunohistochemistry on mouse samples at 1:100 (fig 4). Int J Mol Sci (2021) ncbi
Dako
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; loading ...; fig 2d
Dako KRT15 antibody (Dako, M351501-2) was used in immunohistochemistry on human samples (fig 2d). Commun Biol (2021) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 3b
Dako KRT15 antibody (DAKO, M351501-2) was used in immunohistochemistry - paraffin section on human samples (fig 3b). Cell Rep (2021) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 1:200; fig s7b
Dako KRT15 antibody (Dako, AE1/AE3, M3515,) was used in immunohistochemistry on human samples at 1:200 (fig s7b). Nature (2021) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200; fig 5j
Dako KRT15 antibody (Dako, M3515) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 5j). Acta Neuropathol (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; loading ...
Dako KRT15 antibody (Dako, AE1/AE3) was used in immunohistochemistry on human samples . Anal Cell Pathol (Amst) (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; mouse; loading ...; fig 5b
Dako KRT15 antibody (DAKO, M3515) was used in immunohistochemistry on mouse samples (fig 5b). Oncoimmunology (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; loading ...; fig 3c
Dako KRT15 antibody (DAKO, M351529-2) was used in immunohistochemistry on human samples (fig 3c). Cell (2019) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2d
Dako KRT15 antibody (Dako, M3515) was used in immunohistochemistry - paraffin section on human samples (fig 2d). Cancer Cell (2019) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 1s1g
Dako KRT15 antibody (Dako, M351529) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 1s1g). elife (2019) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 6a
Dako KRT15 antibody (Dako, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples (fig 6a). J Clin Invest (2018) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1
  • immunocytochemistry; human; 1:100; fig s4
In order to elucidate the clinical importance of IDO1 protein in hormone receptor-positive breast cancer, Dako KRT15 antibody (Dako, M3515) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1) and in immunocytochemistry on human samples at 1:100 (fig s4). J Immunother Cancer (2017) ncbi
mouse monoclonal (AE1/AE3)
  • western blot; human; 1:4000; loading ...; fig 5d
Dako KRT15 antibody (Dako, M3515) was used in western blot on human samples at 1:4000 (fig 5d). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (MNF116)
  • immunohistochemistry; human; 1:300; fig 10c
Dako KRT15 antibody (Dako, M0821) was used in immunohistochemistry on human samples at 1:300 (fig 10c). Development (2017) ncbi
mouse monoclonal (34?E12)
  • immunohistochemistry - paraffin section; human; 1:40; loading ...; fig 3
Dako KRT15 antibody (Dako, 34E12) was used in immunohistochemistry - paraffin section on human samples at 1:40 (fig 3). Hum Pathol (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 3d
In order to develop a microfluidic immunostaining system for the standardization of immunohistochemical assays, Dako KRT15 antibody (Dako, M3515) was used in immunohistochemistry - paraffin section on human samples (fig 3d). Sci Rep (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100; fig 5a
Dako KRT15 antibody (DAKO, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 5a). Mol Cancer Res (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; pigs ; 1:100; fig 2
Dako KRT15 antibody (Dako, AE1/AE3) was used in immunocytochemistry on pigs samples at 1:100 (fig 2). PLoS ONE (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; rat; loading ...; fig 81
In order to outline the protocols for antibodies used for immunohistochemical studies, Dako KRT15 antibody (Dako, IR053) was used in immunohistochemistry on rat samples (fig 81). J Toxicol Pathol (2017) ncbi
mouse monoclonal (34?E12)
  • immunohistochemistry; rat; loading ...; fig 85
In order to outline the protocols for antibodies used for immunohistochemical studies, Dako KRT15 antibody (Dako, M0630) was used in immunohistochemistry on rat samples (fig 85). J Toxicol Pathol (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; dogs; 1:200; fig 5b,6b,7b,b8b
In order to characterize an atypical cutaneous tumor of a 9-year-old mixed breed female dog, Dako KRT15 antibody (Dako, AE1/AE3) was used in immunohistochemistry on dogs samples at 1:200 (fig 5b,6b,7b,b8b). J Vet Med Sci (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 1:100; loading ...; fig 1a
In order to study the invasion of maternal endometrium by extravillous trophoblasts., Dako KRT15 antibody (Dako, AE1/AE3) was used in immunohistochemistry on human samples at 1:100 (fig 1a). PLoS ONE (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 4g
Dako KRT15 antibody (Dako, Cytokeratin) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 4g). Oncotarget (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:60; fig 3a
In order to discuss the relevance of vasculogenic mimicry in small cell lung cancer, Dako KRT15 antibody (Dako, M3515) was used in immunohistochemistry - paraffin section on human samples at 1:60 (fig 3a). Nat Commun (2016) ncbi
mouse monoclonal (MNF116)
  • immunohistochemistry - paraffin section; pigs ; 1:300; fig 5d
In order to investigate the regenerative capacity of the muscular bladder wall, Dako KRT15 antibody (DakoCytomation, M0821) was used in immunohistochemistry - paraffin section on pigs samples at 1:300 (fig 5d). Biomed Res Int (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 1:75; loading ...; fig 3b
Dako KRT15 antibody (Dako, M3515) was used in immunohistochemistry on human samples at 1:75 (fig 3b). Nat Med (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 1:200; fig 2g
Dako KRT15 antibody (Dako, AE1/AE3) was used in immunohistochemistry on human samples at 1:200 (fig 2g). Diagn Pathol (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; dogs; 1:500; tbl 5
In order to establish canine mammary tissue derived cell lines and study claudin expression, Dako KRT15 antibody (Dako, AE1/AE3) was used in immunocytochemistry on dogs samples at 1:500 (tbl 5). Int J Mol Sci (2016) ncbi
mouse monoclonal (MNF116)
  • immunocytochemistry; dogs; 1:1000; tbl 5
In order to establish canine mammary tissue derived cell lines and study claudin expression, Dako KRT15 antibody (Dako, MNF116) was used in immunocytochemistry on dogs samples at 1:1000 (tbl 5). Int J Mol Sci (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; 1 ug/ml; loading ...; fig 5e
In order to investigate the alternative splicing of E-cadherin mRNA, Dako KRT15 antibody (Dako, AE1/AE3) was used in immunocytochemistry on human samples at 1 ug/ml (fig 5e). J Cell Physiol (2017) ncbi
mouse monoclonal (MNF116)
  • western blot; human; 1:4000; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Dako KRT15 antibody (Dako, M0821) was used in western blot on human samples at 1:4000 (fig st1). Nat Commun (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:1000; fig 3
In order to determine mediation of differentiation and cisplatin chemotherapy resistance by biased expression of the FOXP3delta3 isoform in aggressive bladder cancer, Dako KRT15 antibody (Dako, M3515) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 3). Clin Cancer Res (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; fig 2
Dako KRT15 antibody (Dako, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples (fig 2). J Exp Clin Cancer Res (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; 1:100
Dako KRT15 antibody (Dako, M3515) was used in immunocytochemistry on human samples at 1:100. PLoS ONE (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; loading ...; fig s6
In order to study the expression and functional role of stabilin-1 in breast cancer, Dako KRT15 antibody (Dako, AE1/AE3) was used in immunohistochemistry on human samples (fig s6). Oncotarget (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; fig 4b
Dako KRT15 antibody (Dako, M3515) was used in immunohistochemistry - paraffin section on human samples (fig 4b). Autophagy (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:60; fig 2e
Dako KRT15 antibody (Dako, M3515) was used in immunohistochemistry - paraffin section on human samples at 1:60 (fig 2e). Ann Oncol (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
Dako KRT15 antibody (DAKO, M3515) was used in immunohistochemistry - paraffin section on human samples at 1:100. Sci Rep (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; tbl 1
In order to examine eosinophilic neuronal cytoplasmic inclusions, Dako KRT15 antibody (DAKO, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 1). Neuropathology (2016) ncbi
mouse monoclonal (34?E12)
  • immunohistochemistry - paraffin section; human; 1:300; loading ...
Dako KRT15 antibody (Dako, M0630) was used in immunohistochemistry - paraffin section on human samples at 1:300. Oncol Lett (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...
In order to characterize and present the first case of fibroblastic reticular cell tumor of the breast, Dako KRT15 antibody (Dako, AE1/AE) was used in immunohistochemistry - paraffin section on human samples at 1:100. Exp Ther Med (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; tbl s2
In order to use microfluidic immunofluorescence staining to quantify HER2 gene copies, Dako KRT15 antibody (Dako, M3515) was used in immunohistochemistry - paraffin section on human samples (tbl s2). Sci Rep (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; dogs; 1:1500; loading ...; fig 1d
In order to study canine prostate cancer cell line CHP-1 and co-chaperone small glutamine-rich tetratricopeptide repeat-containing protein, Dako KRT15 antibody (Dako, AE1/AE3) was used in immunohistochemistry - paraffin section on dogs samples at 1:1500 (fig 1d). Vet Comp Oncol (2017) ncbi
mouse monoclonal (MNF116)
  • immunocytochemistry; rat; 1:50; fig s1
In order to assess the role of platelet endothelial cell adhesion molecule-1 cleavage in delayed microvascular shear adaptation in pulmonary arterial hypertension, Dako KRT15 antibody (Dako, MNF116) was used in immunocytochemistry on rat samples at 1:50 (fig s1). Am J Respir Crit Care Med (2016) ncbi
mouse monoclonal (34?E12)
  • immunohistochemistry; human; 1:100; fig e5
In order to study triple-negative breast cancer and BET bromodomain inhibitor response and resistance, Dako KRT15 antibody (Dako, M0630) was used in immunohistochemistry on human samples at 1:100 (fig e5). Nature (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 1:2; loading ...; fig 1a
In order to characterize circulating tumor cells and determine prognostic markers for pancreatic ductal adenocarcinoma, Dako KRT15 antibody (Dako, IR053) was used in immunohistochemistry on human samples at 1:2 (fig 1a). Tumour Biol (2016) ncbi
mouse monoclonal (MNF116)
  • immunohistochemistry; mouse; 1:100; fig s4c
In order to determine the role of Vhl in mesenchymal cells, Dako KRT15 antibody (Dako, M0821) was used in immunohistochemistry on mouse samples at 1:100 (fig s4c). Am J Pathol (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; fig 7
Dako KRT15 antibody (Dako, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples (fig 7). Am J Physiol Renal Physiol (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200; fig 2
In order to assess the activity of a novel dual PI3K/mTOR inhibitor on mesothelioma, Dako KRT15 antibody (DAKO, M3515) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100; fig 6
In order to characterize a conditional knock out of ataxia telangiectasia-mutated as a mouse model of pancreatic ductal adenocarcinoma, Dako KRT15 antibody (DAKO, M3515) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 6). Nat Commun (2015) ncbi
mouse monoclonal (34?E12)
  • immunohistochemistry - paraffin section; human; 1:200; tbl 2
In order to characterize triple-negative breast cancer and the role of epithelial-mesenchymal transition markers, Dako KRT15 antibody (Dako, M0630) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 2). Breast Cancer Res Treat (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; dogs; loading ...; fig 3a
Dako KRT15 antibody (Dako, AE1/AE3) was used in immunohistochemistry - paraffin section on dogs samples (fig 3a). Acta Vet Scand (2015) ncbi
mouse monoclonal (34?E12)
  • immunohistochemistry - paraffin section; human; 1:200
In order to assess the clinicopathological and immunohistochemical characteristics, and the clinical outcomes, between screen-detected and symptomatic DCIS, Dako KRT15 antibody (DakoCytomation, M0630) was used in immunohistochemistry - paraffin section on human samples at 1:200. Breast Cancer Res Treat (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 1:100
Dako KRT15 antibody (Dako, AE1/AE3) was used in immunohistochemistry on human samples at 1:100. Hum Pathol (2015) ncbi
mouse monoclonal (MNF116)
  • immunocytochemistry; human; 1:200
Dako KRT15 antibody (Dako, M0821) was used in immunocytochemistry on human samples at 1:200. Female Pelvic Med Reconstr Surg (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:500; fig 4
Dako KRT15 antibody (Dako, M3515) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 4). Mol Cancer (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human
In order to assess the use of epithelial-mesenchymal transition-related biomarker plastin3 (PLS3) as a prognostic factor for breast cancer, Dako KRT15 antibody (Dako, AE1/AE3) was used in immunocytochemistry on human samples . Br J Cancer (2015) ncbi
mouse monoclonal (34?E12)
  • immunohistochemistry; human; 1:200
In order to evaluate the presence of cancer stem cells and EMT markers as prognostic markers for breast metaplastic carcinoma, Dako KRT15 antibody (Dako, M0630) was used in immunohistochemistry on human samples at 1:200. Breast Cancer Res Treat (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:5000
Dako KRT15 antibody (Dako, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:5000. World J Gastroenterol (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human
Dako KRT15 antibody (Dako, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples . Oncol Lett (2015) ncbi
mouse monoclonal (MNF116)
  • immunohistochemistry; human; 1 ug/ml; fig 2b
Dako KRT15 antibody (Dako, M0821) was used in immunohistochemistry on human samples at 1 ug/ml (fig 2b). J Allergy Clin Immunol (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human
Dako KRT15 antibody (Dako, AE1/AE3) was used in immunocytochemistry on human samples . Int J Biochem Cell Biol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; bovine; fig 1
Dako KRT15 antibody (Dako, M3515) was used in immunohistochemistry on bovine samples (fig 1). Vet Res (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200
Dako KRT15 antibody (DAKO, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:200. Endocr Pathol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 1:40
In order to describe the histological features canalicular adenoma, Dako KRT15 antibody (Dako, AE1/AE3:M3515) was used in immunohistochemistry on human samples at 1:40. Head Neck Pathol (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human
Dako KRT15 antibody (Dako, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples . Virchows Arch (2014) ncbi
mouse monoclonal (MNF116)
  • immunohistochemistry - paraffin section; human
In order to study ezrin, Cx43 and PKA in cell fusion in cytotrophoblasts, Dako KRT15 antibody (Dako, M0821) was used in immunohistochemistry - paraffin section on human samples . J Cell Sci (2014) ncbi
mouse monoclonal (MNF116)
  • immunohistochemistry - paraffin section; human
Dako KRT15 antibody (Dako Cytomation, M 0821) was used in immunohistochemistry - paraffin section on human samples . Oral Oncol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 1:50
In order to study the genetic profiles of morphologically indistinguishable primary and secondary angiosarcomas, Dako KRT15 antibody (Dako, AE1/AE3) was used in immunohistochemistry on human samples at 1:50. Br J Cancer (2014) ncbi
mouse monoclonal (MNF116)
  • immunohistochemistry; South American coati; 1:300
Dako KRT15 antibody (Dako, M0821) was used in immunohistochemistry on South American coati samples at 1:300. Reprod Biol Endocrinol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:800
  • immunocytochemistry; human; 1:50
  • western blot; human; 1:1000
Dako KRT15 antibody (Dako, M3515) was used in immunohistochemistry - paraffin section on human samples at 1:800, in immunocytochemistry on human samples at 1:50 and in western blot on human samples at 1:1000. BMC Cancer (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
In order to study the claudin expression in fibromatosis-like metaplastic carcinoma of the breast, Dako KRT15 antibody (Dako, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Virchows Arch (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 1:100
Dako KRT15 antibody (Dako, AE1/AE3) was used in immunohistochemistry on human samples at 1:100. Pathol Res Pract (2014) ncbi
mouse monoclonal (MNF116)
  • immunohistochemistry - paraffin section; human; fig 7b
Dako KRT15 antibody (Dako, MNF116) was used in immunohistochemistry - paraffin section on human samples (fig 7b). Nat Commun (2014) ncbi
mouse monoclonal (MNF116)
  • immunocytochemistry; human; 1:200
Dako KRT15 antibody (Dako, M0821) was used in immunocytochemistry on human samples at 1:200. Biol Reprod (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:50
In order to investigate the association of eosinophilic neuronal cytoplasmic inclusions with stress granules and autophagy in two clinical cases, Dako KRT15 antibody (DAKO, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:50. Neuropathology (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human
Dako KRT15 antibody (Dako, AE1/AE3) was used in immunocytochemistry on human samples . J Cancer (2014) ncbi
mouse monoclonal (MNF116)
  • immunocytochemistry; human
Dako KRT15 antibody (Dako, MNF116) was used in immunocytochemistry on human samples . J Cancer (2014) ncbi
mouse monoclonal (MNF116)
  • immunohistochemistry - frozen section; human
Dako KRT15 antibody (Dako, M0821) was used in immunohistochemistry - frozen section on human samples . Ann Neurol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:50
In order to assess the effects of a novel Gemini vitamin D analog on breast cancer progression, Dako KRT15 antibody (Dako, M3515) was used in immunohistochemistry - paraffin section on human samples at 1:50. Cancer Prev Res (Phila) (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; bovine
Dako KRT15 antibody (Dako, M3515) was used in immunohistochemistry - paraffin section on bovine samples . Int J Mol Sci (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:50
Dako KRT15 antibody (Dako, M3515) was used in immunohistochemistry - paraffin section on human samples at 1:50. Exp Mol Pathol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human
Dako KRT15 antibody (DakoCytomation, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples . Oncol Lett (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human
Dako KRT15 antibody (Dako, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples . Int J Gynecol Pathol (2014) ncbi
mouse monoclonal (MNF116)
  • immunohistochemistry - paraffin section; human; fig 2
  • immunocytochemistry; human
Dako KRT15 antibody (DAKO, M0821) was used in immunohistochemistry - paraffin section on human samples (fig 2) and in immunocytochemistry on human samples . Breast Cancer Res (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
  • immunocytochemistry; human; 1:100
Dako KRT15 antibody (Dako, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100 and in immunocytochemistry on human samples at 1:100. Clin Cancer Res (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:50
Dako KRT15 antibody (Dako, M3515) was used in immunohistochemistry - paraffin section on human samples at 1:50. FASEB J (2014) ncbi
mouse monoclonal (MNF116)
  • immunohistochemistry; human; 1:400; tbl 1
In order to report on a case of plexiform fibromyxoma of the stomach, Dako KRT15 antibody (Dako, MNF116) was used in immunohistochemistry on human samples at 1:400 (tbl 1). Int J Surg Pathol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200
Dako KRT15 antibody (Dako, M3515) was used in immunohistochemistry - paraffin section on human samples at 1:200. PLoS ONE (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200
Dako KRT15 antibody (Dako, M3515) was used in immunohistochemistry - paraffin section on human samples at 1:200. PLoS ONE (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 1:100
Dako KRT15 antibody (Dako, AE1/AE3) was used in immunohistochemistry on human samples at 1:100. Mol Carcinog (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; rat; 1:50
Dako KRT15 antibody (Dako, M3515) was used in immunohistochemistry - paraffin section on rat samples at 1:50. PLoS ONE (2012) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; rat; 1:50; tbl 3
Dako KRT15 antibody (dako, M3515) was used in immunohistochemistry - paraffin section on rat samples at 1:50 (tbl 3). Dis Model Mech (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human
In order to measure the expression of epithelial-to-mesenchymal transition-associated proteins in renal cell carcinoma and compared expression levels with clinical outcome, Dako KRT15 antibody (Dako, M3515) was used in immunocytochemistry on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 1:1000
Dako KRT15 antibody (Dako Cytomation, AE1/AE3) was used in immunohistochemistry on human samples at 1:1000. Pathol Int (2011) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human
Dako KRT15 antibody (Dako, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples . Mediators Inflamm (2009) ncbi
BD Biosciences
mouse monoclonal (CAM 5.2)
  • flow cytometry; mouse; 1:200; loading ...; fig s7d
BD Biosciences KRT15 antibody (BD Biosciences, 563613) was used in flow cytometry on mouse samples at 1:200 (fig s7d). Nat Neurosci (2018) ncbi
Articles Reviewed
  1. Liu M, Liu Z, Chen Y, Peng S, Yang J, Chen C, et al. Dendritic epidermal T cells secreting exosomes promote the proliferation of epidermal stem cells to enhance wound re-epithelialization. Stem Cell Res Ther. 2022;13:121 pubmed publisher
  2. Rodriguez E, Boelaars K, Brown K, Madunić K, van Ee T, Dijk F, et al. Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits. Commun Biol. 2022;5:41 pubmed publisher
  3. Bruun J, Eide P, Bergsland C, Brück O, Svindland A, Arjama M, et al. E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models. Mol Oncol. 2022;16:2312-2329 pubmed publisher
  4. Walker H, Taiyab A, Deschamps P, Williams T, West Mays J. Conditional Deletion of AP-2β in the Periocular Mesenchyme of Mice Alters Corneal Epithelial Cell Fate and Stratification. Int J Mol Sci. 2021;22: pubmed publisher
  5. Li X, Yang H, Zhang Y, Du X, Yan Z, Li J, et al. CGFe and TGF-β1 enhance viability and osteogenic differentiation of human dental pulp stem cells through the MAPK pathway. Exp Ther Med. 2021;22:1048 pubmed publisher
  6. Strait A, Woolaver R, Hall S, Young C, Karam S, Jimeno A, et al. Distinct immune microenvironment profiles of therapeutic responders emerge in combined TGFβ/PD-L1 blockade-treated squamous cell carcinoma. Commun Biol. 2021;4:1005 pubmed publisher
  7. Bruand M, Barras D, Mina M, Ghisoni E, Morotti M, Lanitis E, et al. Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING. Cell Rep. 2021;36:109412 pubmed publisher
  8. Barthet V, Brucoli M, Ladds M, Nössing C, Kiourtis C, Baudot A, et al. Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver. Sci Adv. 2021;7: pubmed publisher
  9. Eriksen A, Møller R, Makovoz B, Uhl S, tenOever B, Blenkinsop T. SARS-CoV-2 infects human adult donor eyes and hESC-derived ocular epithelium. Cell Stem Cell. 2021;28:1205-1220.e7 pubmed publisher
  10. Ryu Y, Lee D, Shim J, Park J, Kim Y, Choi S, et al. KY19382, a novel activator of Wnt/β-catenin signalling, promotes hair regrowth and hair follicle neogenesis. Br J Pharmacol. 2021;178:2533-2546 pubmed publisher
  11. Rodriguez E, Boelaars K, Brown K, Eveline Li R, Kruijssen L, Bruijns S, et al. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9. Nat Commun. 2021;12:1270 pubmed publisher
  12. Biswas S, Mandal G, Payne K, Anadon C, Gatenbee C, Chaurio R, et al. IgA transcytosis and antigen recognition govern ovarian cancer immunity. Nature. 2021;591:464-470 pubmed publisher
  13. Biasci D, Smoragiewicz M, Connell C, Wang Z, Gao Y, Thaventhiran J, et al. CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response. Proc Natl Acad Sci U S A. 2020;117:28960-28970 pubmed publisher
  14. Schweizer L, Thierfelder F, Thomas C, Soschinski P, Suwala A, Stichel D, et al. Molecular characterization of CNS paragangliomas identifies cauda equina paragangliomas as a distinct tumor entity. Acta Neuropathol. 2020;140:893-906 pubmed publisher
  15. Ge W, Tan S, Wang S, Li L, Sun X, Shen W, et al. Single-cell Transcriptome Profiling reveals Dermal and Epithelial cell fate decisions during Embryonic Hair Follicle Development. Theranostics. 2020;10:7581-7598 pubmed publisher
  16. Zhou L, Wang A, Yu G, Zhou J, Xu H, Wang C. The Diagnostic and Clinical Significance of TFE3 Immunohistochemical Nuclear Expression in Solitary Fibrous Tumour. Anal Cell Pathol (Amst). 2020;2020:8232803 pubmed publisher
  17. Chandrashekar A, Liu J, Martinot A, McMahan K, Mercado N, Peter L, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;: pubmed publisher
  18. Gaglia G, Rashid R, Yapp C, Joshi G, Li C, Lindquist S, et al. HSF1 phase transition mediates stress adaptation and cell fate decisions. Nat Cell Biol. 2020;22:151-158 pubmed publisher
  19. Seitz C, Schroeder S, Knopf P, Krahl A, Hau J, Schleicher S, et al. GD2-targeted chimeric antigen receptor T cells prevent metastasis formation by elimination of breast cancer stem-like cells. Oncoimmunology. 2020;9:1683345 pubmed publisher
  20. Foster A, El Chami C, O Neill C, Watson R. Osmolyte transporter expression is reduced in photoaged human skin: Implications for skin hydration in aging. Aging Cell. 2020;19:e13058 pubmed publisher
  21. Ramani V, Lemaire C, Triboulet M, Casey K, Heirich K, Renier C, et al. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer. Breast Cancer Res. 2019;21:98 pubmed publisher
  22. Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, et al. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. Cell. 2019;178:795-806.e12 pubmed publisher
  23. Dangaj D, Bruand M, Grimm A, Ronet C, Barras D, Duttagupta P, et al. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors. Cancer Cell. 2019;35:885-900.e10 pubmed publisher
  24. Zhou H, Wang L, Zhang C, Hu J, Chen J, Du W, et al. Feasibility of repairing full-thickness skin defects by iPSC-derived epithelial stem cells seeded on a human acellular amniotic membrane. Stem Cell Res Ther. 2019;10:155 pubmed publisher
  25. Lodge E, Santambrogio A, Russell J, Xekouki P, Jacques T, Johnson R, et al. Homeostatic and tumourigenic activity of SOX2+ pituitary stem cells is controlled by the LATS/YAP/TAZ cascade. elife. 2019;8: pubmed publisher
  26. Aldehlawi H, Niemiec K, Avisetti D, Lalli A, Teh M, Waseem A. The monoclonal antibody EPR1614Y against the stem cell biomarker keratin K15 lacks specificity and reacts with other keratins. Sci Rep. 2019;9:1943 pubmed publisher
  27. Louveau A, Herz J, Alme M, Salvador A, Dong M, Viar K, et al. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat Neurosci. 2018;21:1380-1391 pubmed publisher
  28. Lin H, Wei S, Hurt E, Green M, Zhao L, Vatan L, et al. Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression. J Clin Invest. 2018;128:805-815 pubmed publisher
  29. Carvajal Hausdorf D, Mani N, Velcheti V, Schalper K, Rimm D. Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer. J Immunother Cancer. 2017;5:81 pubmed publisher
  30. Gesteira T, Sun M, Coulson Thomas Y, Yamaguchi Y, Yeh L, Hascall V, et al. Hyaluronan Rich Microenvironment in the Limbal Stem Cell Niche Regulates Limbal Stem Cell Differentiation. Invest Ophthalmol Vis Sci. 2017;58:4407-4421 pubmed publisher
  31. Aprile F, Källstig E, Limorenko G, Vendruscolo M, Ron D, Hansen C. The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress α-synuclein aggregation. Sci Rep. 2017;7:9039 pubmed publisher
  32. Wang R, Cao X, Kulej K, Liu W, Ma T, MacDonald M, et al. Uncovering BRD4 hyperphosphorylation associated with cellular transformation in NUT midline carcinoma. Proc Natl Acad Sci U S A. 2017;114:E5352-E5361 pubmed publisher
  33. Haston S, Pozzi S, Carreno G, Manshaei S, Panousopoulos L, González Meljem J, et al. MAPK pathway control of stem cell proliferation and differentiation in the embryonic pituitary provides insights into the pathogenesis of papillary craniopharyngioma. Development. 2017;144:2141-2152 pubmed publisher
  34. Posenato I, Caliò A, Segala D, Sgroi S, Polara A, Brunelli M, et al. Primary seminal vesicle carcinoma. The usefulness of PAX8 immunohistochemical expression for the differential diagnosis. Hum Pathol. 2017;69:123-128 pubmed publisher
  35. Kwon S, Cho C, Kwon Y, Lee E, Park J. A Microfluidic Immunostaining System Enables Quality Assured and Standardized Immunohistochemical Biomarker Analysis. Sci Rep. 2017;7:45968 pubmed publisher
  36. Wang X, Xia Q, Ni H, Ye S, Li R, Wang X, et al. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion. Hum Pathol. 2017;63:190-200 pubmed publisher
  37. Moore L, England A, Ehrlich B, Rimm D. Calcium Sensor, NCS-1, Promotes Tumor Aggressiveness and Predicts Patient Survival. Mol Cancer Res. 2017;15:942-952 pubmed publisher
  38. Palma Vera S, Schoen J, Chen S. Periovulatory follicular fluid levels of estradiol trigger inflammatory and DNA damage responses in oviduct epithelial cells. PLoS ONE. 2017;12:e0172192 pubmed publisher
  39. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed publisher
  40. Watanabe K, Chambers J, Uchida K, Nibe K, Ushio N, Horiuchi N, et al. A cutaneous mixed tumor in a dog. J Vet Med Sci. 2017;79:670-673 pubmed publisher
  41. He N, van Iperen L, de Jong D, Szuhai K, Helmerhorst F, van der Westerlaken L, et al. Human Extravillous Trophoblasts Penetrate Decidual Veins and Lymphatics before Remodeling Spiral Arteries during Early Pregnancy. PLoS ONE. 2017;12:e0169849 pubmed publisher
  42. De Luca Johnson J, Zenali M. A Previously Undescribed Presentation of Mixed Adenoneuroendocrine Carcinoma. Case Rep Pathol. 2016;2016:9063634 pubmed
  43. Farsam V, Basu A, Gatzka M, Treiber N, Schneider L, Mulaw M, et al. Senescent fibroblast-derived Chemerin promotes squamous cell carcinoma migration. Oncotarget. 2016;7:83554-83569 pubmed publisher
  44. Williamson S, Metcalf R, Trapani F, Mohan S, Antonello J, Abbott B, et al. Vasculogenic mimicry in small cell lung cancer. Nat Commun. 2016;7:13322 pubmed publisher
  45. Reinfeldt Engberg G, Chamorro C, Nordenskjold A, Fossum M. Expansion of Submucosal Bladder Wall Tissue In Vitro and In Vivo. Biomed Res Int. 2016;2016:5415012 pubmed
  46. Frentzas S, Simoneau E, Bridgeman V, Vermeulen P, Foo S, Kostaras E, et al. Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases. Nat Med. 2016;22:1294-1302 pubmed publisher
  47. Yu L, Li J, Xu S, Navia Miranda M, Wang G, Duan Y. An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report. Diagn Pathol. 2016;11:98 pubmed
  48. Hammer S, Becker A, Rateitschak K, Mohr A, Lüder Ripoli F, Hennecke S, et al. Longitudinal Claudin Gene Expression Analyses in Canine Mammary Tissues and Thereof Derived Primary Cultures and Cell Lines. Int J Mol Sci. 2016;17: pubmed
  49. Matos M, Lapyckyj L, Rosso M, Besso M, Mencucci M, Briggiler C, et al. Identification of a Novel Human E-Cadherin Splice Variant and Assessment of Its Effects Upon EMT-Related Events. J Cell Physiol. 2017;232:1368-1386 pubmed publisher
  50. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed publisher
  51. Cammareri P, Rose A, Vincent D, Wang J, Nagano A, Libertini S, et al. Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma. Nat Commun. 2016;7:12493 pubmed publisher
  52. Shin H, Yoon J, Koh W, Kim J, Kim C, Han K, et al. Nonpigmented hair removal using photodynamic therapy in animal model. Lasers Surg Med. 2016;48:748-762 pubmed publisher
  53. Berens E, Sharif G, Schmidt M, Yan G, Shuptrine C, Weiner L, et al. Keratin-associated protein 5-5 controls cytoskeletal function and cancer cell vascular invasion. Oncogene. 2017;36:593-605 pubmed publisher
  54. Szalayova G, Ogrodnik A, Spencer B, Wade J, Bunn J, Ambaye A, et al. Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation. Breast Cancer Res Treat. 2016;157:461-74 pubmed publisher
  55. Zhang H, Prado K, Zhang K, Peek E, Lee J, Wang X, et al. Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance. Clin Cancer Res. 2016;22:5349-5361 pubmed
  56. Hamam D, Abdouh M, Gao Z, Arena V, Arena M, Arena G. Transfer of malignant trait to BRCA1 deficient human fibroblasts following exposure to serum of cancer patients. J Exp Clin Cancer Res. 2016;35:80 pubmed publisher
  57. Fabbri R, Macciocca M, Vicenti R, Paradisi R, Klinger F, Pasquinelli G, et al. Doxorubicin and cisplatin induce apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue. Future Oncol. 2016;12:1699-711 pubmed publisher
  58. Kayamori K, Katsube K, Sakamoto K, Ohyama Y, Hirai H, Yukimori A, et al. NOTCH3 Is Induced in Cancer-Associated Fibroblasts and Promotes Angiogenesis in Oral Squamous Cell Carcinoma. PLoS ONE. 2016;11:e0154112 pubmed publisher
  59. Riabov V, Yin S, Song B, Avdic A, Schledzewski K, Ovsiy I, et al. Stabilin-1 is expressed in human breast cancer and supports tumor growth in mammary adenocarcinoma mouse model. Oncotarget. 2016;7:31097-110 pubmed publisher
  60. Follo C, Barbone D, Richards W, Bueno R, Broaddus V. Autophagy initiation correlates with the autophagic flux in 3D models of mesothelioma and with patient outcome. Autophagy. 2016;12:1180-94 pubmed publisher
  61. Seidel P, Remus M, Delacher M, Grigaravicius P, Reuss D, Frappart L, et al. Epidermal Nbn deletion causes premature hair loss and a phenotype resembling psoriasiform dermatitis. Oncotarget. 2016;7:23006-18 pubmed publisher
  62. Yosef R, Pilpel N, Tokarsky Amiel R, Biran A, Ovadya Y, Cohen S, et al. Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nat Commun. 2016;7:11190 pubmed publisher
  63. Morrow C, Trapani F, Metcalf R, Bertolini G, Hodgkinson C, Khandelwal G, et al. Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study. Ann Oncol. 2016;27:1155-60 pubmed publisher
  64. Guo X, Hollander L, MacPherson D, Wang L, Velazquez H, Chang J, et al. Inhibition of renalase expression and signaling has antitumor activity in pancreatic cancer. Sci Rep. 2016;6:22996 pubmed publisher
  65. Ito M, Nakamura K, Mori F, Miki Y, Tanji K, Wakabayashi K. Novel eosinophilic neuronal cytoplasmic inclusions in the external cuneate nucleus of humans. Neuropathology. 2016;36:441-447 pubmed publisher
  66. Ji C, Zhou M, Gan W, Zheng J, Yan X, Guo H. Advanced prostatic ductal carcinoma in a patient with a long survival time following a total pelvis exenteration: A case report. Oncol Lett. 2016;11:1509-1511 pubmed
  67. Li H, Shen P, Liang Y, Zhang F. Fibroblastic reticular cell tumor of the breast: A case report and review of the literature. Exp Ther Med. 2016;11:561-564 pubmed
  68. Dupouy D, Ciftlik A, Fiche M, Heintze D, Bisig B, de Leval L, et al. Continuous quantification of HER2 expression by microfluidic precision immunofluorescence estimates HER2 gene amplification in breast cancer. Sci Rep. 2016;6:20277 pubmed publisher
  69. Kramerov A, Saghizadeh M, Maguen E, Rabinowitz Y, Ljubimov A. Persistence of reduced expression of putative stem cell markers and slow wound healing in cultured diabetic limbal epithelial cells. Mol Vis. 2015;21:1357-67 pubmed
  70. Azakami D, Nakahira R, Kato Y, Michishita M, Onozawa E, Bonkobara M, et al. The canine prostate cancer cell line CHP-1 shows over-expression of the co-chaperone small glutamine-rich tetratricopeptide repeat-containing protein α. Vet Comp Oncol. 2017;15:557-562 pubmed publisher
  71. Szulcek R, Happé C, Rol N, Fontijn R, Dickhoff C, Hartemink K, et al. Delayed Microvascular Shear Adaptation in Pulmonary Arterial Hypertension. Role of Platelet Endothelial Cell Adhesion Molecule-1 Cleavage. Am J Respir Crit Care Med. 2016;193:1410-20 pubmed publisher
  72. Shu S, Lin C, He H, Witwicki R, Tabassum D, Roberts J, et al. Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer. Nature. 2016;529:413-417 pubmed publisher
  73. Kulemann B, Liss A, Warshaw A, Seifert S, Bronsert P, Glatz T, et al. KRAS mutations in pancreatic circulating tumor cells: a pilot study. Tumour Biol. 2016;37:7547-54 pubmed publisher
  74. Mikhailova A, Ilmarinen T, Ratnayake A, Petrovski G, Uusitalo H, Skottman H, et al. Human pluripotent stem cell-derived limbal epithelial stem cells on bioengineered matrices for corneal reconstruction. Exp Eye Res. 2016;146:26-34 pubmed publisher
  75. Shin H, Pei Z, Martinez K, Rivera Viñas J, Méndez K, Cavallin H, et al. The first microbial environment of infants born by C-section: the operating room microbes. Microbiome. 2015;3:59 pubmed publisher
  76. Gao L, Jiang Y, Mu L, Liu Y, Wang F, Wang P, et al. Efficient Generation of Mice with Consistent Transgene Expression by FEEST. Sci Rep. 2015;5:16284 pubmed publisher
  77. Fridriksdottir A, Kim J, Villadsen R, Klitgaard M, Hopkinson B, Petersen O, et al. Propagation of oestrogen receptor-positive and oestrogen-responsive normal human breast cells in culture. Nat Commun. 2015;6:8786 pubmed publisher
  78. Jung M, Ryu Y, Kang G. Investigation of the origin of stromal and endothelial cells at the desmoplastic interface in xenograft tumor in mice. Pathol Res Pract. 2015;211:925-30 pubmed publisher
  79. Li Y, Adomat H, Guns E, Hojabrpour P, Duronio V, Curran T, et al. Identification of a Hematopoietic Cell Dedifferentiation-Inducing Factor. J Cell Physiol. 2016;231:1350-63 pubmed publisher
  80. Mangiavini L, Merceron C, Araldi E, Khatri R, Gerard O Riley R, Wilson T, et al. Fibrosis and hypoxia-inducible factor-1α-dependent tumors of the soft tissue on loss of von Hippel-Lindau in mesenchymal progenitors. Am J Pathol. 2015;185:3090-101 pubmed publisher
  81. Wei G, Rosen S, Dantzler W, Pannabecker T. Architecture of the human renal inner medulla and functional implications. Am J Physiol Renal Physiol. 2015;309:F627-37 pubmed publisher
  82. Barbone D, Follo C, Echeverry N, Gerbaudo V, Klabatsa A, Bueno R, et al. Autophagy Correlates with the Therapeutic Responsiveness of Malignant Pleural Mesothelioma in 3D Models. PLoS ONE. 2015;10:e0134825 pubmed publisher
  83. Russell R, Perkhofer L, Liebau S, Lin Q, Lechel A, Feld F, et al. Loss of ATM accelerates pancreatic cancer formation and epithelial-mesenchymal transition. Nat Commun. 2015;6:7677 pubmed publisher
  84. Sauter J, Ambaye A, Mount S. Increased utilization, verification, and clinical implications of immunocytochemistry: Experience in a northern New England hospital. Diagn Cytopathol. 2015;43:688-95 pubmed publisher
  85. Cheung S, Boey Y, Koh V, Thike A, Lim J, Iqbal J, et al. Role of epithelial-mesenchymal transition markers in triple-negative breast cancer. Breast Cancer Res Treat. 2015;152:489-98 pubmed publisher
  86. Paiva B, Silva J, Ocarino N, Oliveira C, Assis W, Serakides R. A rare case of endometrioma in a bitch. Acta Vet Scand. 2015;57:31 pubmed publisher
  87. Koh V, Lim J, Thike A, Cheok P, Thu M, Tan V, et al. Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients. Breast Cancer Res Treat. 2015;152:293-304 pubmed publisher
  88. Berg A, Soma L, Clark B, Swerdlow S, Roth C. Evaluating breast lymphoplasmacytic infiltrates: a multiparameter immunohistochemical study, including assessment of IgG4. Hum Pathol. 2015;46:1162-70 pubmed publisher
  89. Swaminathan T, Basheer V, Kumar R, Kathirvelpandian A, Sood N, Jena J. Establishment and characterization of fin-derived cell line from ornamental carp, Cyprinus carpio koi, for virus isolation in India. In Vitro Cell Dev Biol Anim. 2015;51:705-13 pubmed publisher
  90. Muhanna N, Mepham A, Mohamadi R, Chan H, Khan T, Akens M, et al. Nanoparticle-based sorting of circulating tumor cells by epithelial antigen expression during disease progression in an animal model. Nanomedicine. 2015;11:1613-20 pubmed publisher
  91. Kershaw S, Cummings J, Morris K, Tugwood J, Dive C. Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cells. BMC Cancer. 2015;15:387 pubmed publisher
  92. Katanov C, Lerrer S, Liubomirski Y, Leider Trejo L, Meshel T, Bar J, et al. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-? and the NF-?B pathway. Stem Cell Res Ther. 2015;6:87 pubmed publisher
  93. Medel S, Alarab M, Kufaishi H, Drutz H, Shynlova O. Attachment of Primary Vaginal Fibroblasts to Absorbable and Nonabsorbable Implant Materials Coated With Platelet-Rich Plasma: Potential Application in Pelvic Organ Prolapse Surgery. Female Pelvic Med Reconstr Surg. 2015;21:190-7 pubmed publisher
  94. Apostoli A, Roche J, Schneider M, SenGupta S, Di Lena M, Rubino R, et al. Opposing roles for mammary epithelial-specific PPARγ signaling and activation during breast tumour progression. Mol Cancer. 2015;14:85 pubmed publisher
  95. Sugimachi K, Gorges T, Bartkowiak K, Yokobori T, Müller V, Shinden Y, et al. Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer. Br J Cancer. 2015;112:1519-26 pubmed publisher
  96. Sood N, Chaudhary D, Pradhan P, Verma D, Raja Swaminathan T, Kushwaha B, et al. Establishment and characterization of a continuous cell line from thymus of striped snakehead, Channa striatus (Bloch 1793). In Vitro Cell Dev Biol Anim. 2015;51:787-96 pubmed publisher
  97. Ahmed H, Abdul Gader Suliman R, Abd El Aziz M, Alshammari F. Immunohistochemical expression of cytokeratins and epithelial membrane protein 2 in nasopharyngeal carcinoma and its potential implications. Asian Pac J Cancer Prev. 2015;16:653-6 pubmed
  98. Oon M, Thike A, Tan S, Tan P. Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast. Breast Cancer Res Treat. 2015;150:31-41 pubmed publisher
  99. Yamada S, Nabeshima A, Noguchi H, Nawata A, Nishii H, Guo X, et al. Coincidence between malignant perivascular epithelioid cell tumor arising in the gastric serosa and lung adenocarcinoma. World J Gastroenterol. 2015;21:1349-56 pubmed publisher
  100. Cao Y, Zhu M, Mao R, Cao R, Yu G, Niu A. Oncocytic carcinoma of the salivary gland with thymoma: A case report and review of the literature. Oncol Lett. 2015;9:681-684 pubmed
  101. Zheng L, Cardaci S, Jerby L, MacKenzie E, Sciacovelli M, Johnson T, et al. Fumarate induces redox-dependent senescence by modifying glutathione metabolism. Nat Commun. 2015;6:6001 pubmed publisher
  102. Suzuki D, Sahu R, Leu N, Senoo M. The carboxy-terminus of p63 links cell cycle control and the proliferative potential of epidermal progenitor cells. Development. 2015;142:282-90 pubmed publisher
  103. BaÅŸak K, KiroÄŸlu K. Multiple oncocytic cystadenoma with intraluminal crystalloids in parotid gland: case report. Medicine (Baltimore). 2014;93:e246 pubmed publisher
  104. Winkler M, Dib C, Ljubimov A, Saghizadeh M. Targeting miR-146a to treat delayed wound healing in human diabetic organ-cultured corneas. PLoS ONE. 2014;9:e114692 pubmed publisher
  105. Saghizadeh M, Dib C, Brunken W, Ljubimov A. Normalization of wound healing and stem cell marker patterns in organ-cultured human diabetic corneas by gene therapy of limbal cells. Exp Eye Res. 2014;129:66-73 pubmed publisher
  106. Stinson S, Amrani Y, Brightling C. D prostanoid receptor 2 (chemoattractant receptor-homologous molecule expressed on TH2 cells) protein expression in asthmatic patients and its effects on bronchial epithelial cells. J Allergy Clin Immunol. 2015;135:395-406 pubmed publisher
  107. Pawelczyk T, Sakowicz Burkiewicz M, Wesserling M, Grden M, Kuczkowski J. Altered response of fibroblasts from human tympanosclerotic membrane to interacting mast cells: implication for tissue remodeling. Int J Biochem Cell Biol. 2014;57:35-44 pubmed publisher
  108. Berghuis L, Abdelaziz K, Bierworth J, Wyer L, Jacob G, Karrow N, et al. Comparison of innate immune agonists for induction of tracheal antimicrobial peptide gene expression in tracheal epithelial cells of cattle. Vet Res. 2014;45:105 pubmed publisher
  109. Beck A, Brooks A, Zeiss C. Invasive ductular carcinoma in 2 rhesus macaques (Macaca mulatta). Comp Med. 2014;64:314-22 pubmed
  110. Lu H, Clauser K, Tam W, Fröse J, Ye X, Eaton E, et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol. 2014;16:1105-17 pubmed publisher
  111. Kasem K, Lam A. Adrenal oncocytic phaeochromocytoma with putative adverse histologic features: a unique case report and review of the literature. Endocr Pathol. 2014;25:416-21 pubmed publisher
  112. Li L, Fan X, Xia Q, Rao Q, Liu B, Yu B, et al. Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis. Hum Pathol. 2014;45:2247-54 pubmed publisher
  113. Costache M, Pătraşcu O, Dumitru A, Costache D, Voinea L, Simionescu O, et al. Histopathological findings concerning ocular melanomas. Rom J Morphol Embryol. 2014;55:649-53 pubmed
  114. Thompson L, Bauer J, Chiosea S, McHugh J, Seethala R, Miettinen M, et al. Canalicular adenoma: a clinicopathologic and immunohistochemical analysis of 67 cases with a review of the literature. Head Neck Pathol. 2015;9:181-95 pubmed publisher
  115. Jeon Y, Moon K, Park S, Chung D. Primary pulmonary myxoid sarcomas with EWSR1-CREB1 translocation might originate from primitive peribronchial mesenchymal cells undergoing (myo)fibroblastic differentiation. Virchows Arch. 2014;465:453-61 pubmed publisher
  116. Guan H, Tan J, Zhang F, Gao L, Bai L, Qi D, et al. Myofibroblasts from salivary gland adenoid cystic carcinomas promote cancer invasion by expressing MMP2 and CXCL12. Histopathology. 2015;66:781-90 pubmed publisher
  117. Coulson Thomas V, Gesteira T, Esko J, KAO W. Heparan sulfate regulates hair follicle and sebaceous gland morphogenesis and homeostasis. J Biol Chem. 2014;289:25211-26 pubmed publisher
  118. Pidoux G, Gerbaud P, Dompierre J, Lygren B, Solstad T, Evain Brion D, et al. A PKA-ezrin-Cx43 signaling complex controls gap junction communication and thereby trophoblast cell fusion. J Cell Sci. 2014;127:4172-85 pubmed publisher
  119. Blioumi E, Chatzidimitriou D, Pazartzi C, Katopodi T, Tzimagiorgis G, Emmanouil Nikoloussi E, et al. Detection and typing of human papillomaviruses (HPV) in malignant, dysplastic, nondysplastic and normal oral epithelium by nested polymerase chain reaction, immunohistochemistry and transitional electron microscopy in patients of northern Greece. Oral Oncol. 2014;50:840-7 pubmed publisher
  120. Styring E, Seinen J, Dominguez Valentin M, Domanski H, Jonsson M, von Steyern F, et al. Key roles for MYC, KIT and RET signaling in secondary angiosarcomas. Br J Cancer. 2014;111:407-12 pubmed publisher
  121. Favaron P, Morini J, Mess A, Miglino M, Ambrosio C. Placentation and fetal membrane development in the South American coati, Nasua nasua (Mammalia, Carnivora, Procyonidae). Reprod Biol Endocrinol. 2014;12:57 pubmed publisher
  122. Rathore K, Cekanova M. Animal model of naturally occurring bladder cancer: characterization of four new canine transitional cell carcinoma cell lines. BMC Cancer. 2014;14:465 pubmed publisher
  123. Rito M, Schmitt F, Pinto A, André S. Fibromatosis-like metaplastic carcinoma of the breast has a claudin-low immunohistochemical phenotype. Virchows Arch. 2014;465:185-91 pubmed publisher
  124. Oishi N, Kondo T, Nakazawa T, Mochizuki K, Kasai K, Inoue T, et al. Thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: case report and literature review. Pathol Res Pract. 2014;210:1142-5 pubmed publisher
  125. Majeed S, Vasudevan L, Chen C, Luo Y, Torres J, Evans T, et al. Clathrin light chains are required for the gyrating-clathrin recycling pathway and thereby promote cell migration. Nat Commun. 2014;5:3891 pubmed publisher
  126. Srikhajon K, Shynlova O, Preechapornprasert A, Chanrachakul B, Lye S. A new role for monocytes in modulating myometrial inflammation during human labor. Biol Reprod. 2014;91:10 pubmed publisher
  127. Mori F, Watanabe Y, Miki Y, Tanji K, Odagiri S, Eto K, et al. Ubiquitin-negative, eosinophilic neuronal cytoplasmic inclusions associated with stress granules and autophagy: an immunohistochemical investigation of two cases. Neuropathology. 2014;34:140-7 pubmed
  128. Woodward W, Krishnamurthy S, Lodhi A, Xiao L, Gong Y, Cristofanilli M, et al. Aldehyde dehydrogenase1 immunohistochemical staining in primary breast cancer cells independently predicted overall survival but did not correlate with the presence of circulating or disseminated tumors cells. J Cancer. 2014;5:360-7 pubmed publisher
  129. Breuer J, Schwab N, Schneider Hohendorf T, Marziniak M, Mohan H, Bhatia U, et al. Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity. Ann Neurol. 2014;75:739-58 pubmed publisher
  130. Wahler J, So J, Kim Y, Liu F, Maehr H, Uskokovic M, et al. Inhibition of the transition of ductal carcinoma in situ to invasive ductal carcinoma by a Gemini vitamin D analog. Cancer Prev Res (Phila). 2014;7:617-26 pubmed publisher
  131. Wang C, Bajikar S, Jamal L, Atkins K, Janes K. A time- and matrix-dependent TGFBR3-JUND-KRT5 regulatory circuit in single breast epithelial cells and basal-like premalignancies. Nat Cell Biol. 2014;16:345-56 pubmed publisher
  132. Lin Y, Kuo K, Wuputra K, Lin S, Ku C, Yang Y, et al. Bovine induced pluripotent stem cells are more resistant to apoptosis than testicular cells in response to mono-(2-ethylhexyl) phthalate. Int J Mol Sci. 2014;15:5011-31 pubmed publisher
  133. Balk Møller E, Kim J, Hopkinson B, Timmermans Wielenga V, Petersen O, Villadsen R. A marker of endocrine receptor-positive cells, CEACAM6, is shared by two major classes of breast cancer: luminal and HER2-enriched. Am J Pathol. 2014;184:1198-208 pubmed publisher
  134. Sørdal Ø, Qvigstad G, Nordrum I, Sandvik A, Gustafsson B, Waldum H. The PAS positive material in gastric cancer cells of signet ring type is not mucin. Exp Mol Pathol. 2014;96:274-8 pubmed publisher
  135. Pontiggia L, Biedermann T, Böttcher Haberzeth S, Oliveira C, Braziulis E, Klar A, et al. De novo epidermal regeneration using human eccrine sweat gland cells: higher competence of secretory over absorptive cells. J Invest Dermatol. 2014;134:1735-1742 pubmed publisher
  136. Ishida M, Iwai M, Yoshida K, Kagotani A, Okabe H. Signet-ring cell melanoma with sentinel lymph node metastasis: A case report with immunohistochemical analysis and review of the clinicopathological features. Oncol Lett. 2014;7:65-68 pubmed
  137. Motomura K, Sumino H, Noguchi A, Horinouchi T, Nakanishi K. Sentinel nodes identified by computed tomography-lymphography accurately stage the axilla in patients with breast cancer. BMC Med Imaging. 2013;13:42 pubmed publisher
  138. Jones H, Gold M, Giannico G, Troutman A, Vnencak Jones C, Schultenover S, et al. Lymphoepithelioma-like carcinoma of the endometrium: immunophenotypic characterization of a rare tumor with microsatellite instability testing. Int J Gynecol Pathol. 2014;33:64-73 pubmed publisher
  139. Hugo H, Pereira L, Suryadinata R, Drabsch Y, Gonda T, Gunasinghe N, et al. Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells. Breast Cancer Res. 2013;15:R113 pubmed publisher
  140. Turcotte S, Gros A, Tran E, Lee C, Wunderlich J, Robbins P, et al. Tumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapy. Clin Cancer Res. 2014;20:331-43 pubmed publisher
  141. Leung Y, Kandyba E, Chen Y, Ruffins S, Kobielak K. Label retaining cells (LRCs) with myoepithelial characteristic from the proximal acinar region define stem cells in the sweat gland. PLoS ONE. 2013;8:e74174 pubmed publisher
  142. Bulysheva A, Bowlin G, Petrova S, Yeudall W. Enhanced chemoresistance of squamous carcinoma cells grown in 3D cryogenic electrospun scaffolds. Biomed Mater. 2013;8:055009 pubmed publisher
  143. Motomura K, Izumi T, Tateishi S, Sumino H, Noguchi A, Horinouchi T, et al. Correlation between the area of high-signal intensity on SPIO-enhanced MR imaging and the pathologic size of sentinel node metastases in breast cancer patients with positive sentinel nodes. BMC Med Imaging. 2013;13:32 pubmed publisher
  144. Ishikawa K, Yoshida S, Nakao S, Nakama T, Kita T, Asato R, et al. Periostin promotes the generation of fibrous membranes in proliferative vitreoretinopathy. FASEB J. 2014;28:131-42 pubmed publisher
  145. Qiu S, Wei X, Huang W, Wu M, Qin Y, Li Y, et al. Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytoma. Sci Rep. 2013;3:2529 pubmed publisher
  146. Hosokawa M, Kenmotsu H, Koh Y, Yoshino T, Yoshikawa T, Naito T, et al. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system. PLoS ONE. 2013;8:e67466 pubmed publisher
  147. Ohta K, Taki M, Ogawa I, Ono S, Mizuta K, Fujimoto S, et al. Malignant ossifying fibromyxoid tumor of the tongue: case report and review of the literature. Head Face Med. 2013;9:16 pubmed publisher
  148. Lee P, Yau D, Lau P, Chan J. Plexiform fibromyxoma (plexiform angiomyxoid myofibroblastic tumor) of stomach: an unusual presentation as a fistulating abscess. Int J Surg Pathol. 2014;22:286-90 pubmed publisher
  149. Hughes M, Jiang T, Lin S, Leung Y, Kobielak K, Widelitz R, et al. Disrupted ectodermal organ morphogenesis in mice with a conditional histone deacetylase 1, 2 deletion in the epidermis. J Invest Dermatol. 2014;134:24-32 pubmed publisher
  150. Nassiri F, Scheithauer B, Corwin D, Kaplan H, Mayberg M, Cusimano M, et al. Invasive thymoma metastatic to the cavernous sinus. Surg Neurol Int. 2013;4:74 pubmed publisher
  151. Zhou J, Chen Z, Malysa A, Li X, Oliveira P, Zhang Y, et al. A kinome screen identifies checkpoint kinase 1 (CHK1) as a sensitizer for RRM1-dependent gemcitabine efficacy. PLoS ONE. 2013;8:e58091 pubmed publisher
  152. Franck D, Gil E, Adam R, Kaplan D, Chung Y, Estrada C, et al. Evaluation of silk biomaterials in combination with extracellular matrix coatings for bladder tissue engineering with primary and pluripotent cells. PLoS ONE. 2013;8:e56237 pubmed publisher
  153. Yang G, Li J, Jin H, Ding H. Is mammary not otherwise specified-type sarcoma with CD10 expression a distinct entity? A rare case report with immunohistochemical and ultrastructural study. Diagn Pathol. 2013;8:14 pubmed publisher
  154. Zhang Y, Lam O, Nguyen M, Ng G, Pear W, Ai W, et al. Mastermind-like transcriptional co-activator-mediated Notch signaling is indispensable for maintaining conjunctival epithelial identity. Development. 2013;140:594-605 pubmed publisher
  155. Weli S, Aamelfot M, Dale O, Koppang E, Falk K. Infectious salmon anaemia virus infection of Atlantic salmon gill epithelial cells. Virol J. 2013;10:5 pubmed publisher
  156. Mennecier G, Torres L, Cogliati B, Sanches D, Mori C, Latorre A, et al. Chronic exposure of lung alveolar epithelial type II cells to tobacco-specific carcinogen NNK results in malignant transformation: a new in vitro lung carcinogenesis model. Mol Carcinog. 2014;53:392-402 pubmed publisher
  157. Peyton C, Burmeister D, Petersen B, Andersson K, Christ G. Characterization of the early proliferative response of the rodent bladder to subtotal cystectomy: a unique model of mammalian organ regeneration. PLoS ONE. 2012;7:e47414 pubmed publisher
  158. McCoy A, Besch Williford C, Franklin C, Weinstein E, Cui X. Creation and preliminary characterization of a Tp53 knockout rat. Dis Model Mech. 2013;6:269-78 pubmed publisher
  159. Lv S, Song Y, Xu J, Shu H, Zhou Z, An N, et al. A novel TP53 somatic mutation involved in the pathogenesis of pediatric choroid plexus carcinoma. Med Sci Monit. 2012;18:CS37-41 pubmed
  160. O Mahony F, Faratian D, Varley J, Nanda J, Theodoulou M, Riddick A, et al. The use of automated quantitative analysis to evaluate epithelial-to-mesenchymal transition associated proteins in clear cell renal cell carcinoma. PLoS ONE. 2012;7:e31557 pubmed publisher
  161. Sohn W, Gwon G, An C, Moon C, Bae Y, Yamamoto H, et al. Morphological evidences in circumvallate papilla and von Ebners' gland development in mice. Anat Cell Biol. 2011;44:274-83 pubmed publisher
  162. Khoja L, Backen A, Sloane R, Menasce L, Ryder D, Krebs M, et al. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer. 2012;106:508-16 pubmed publisher
  163. Yamada Y, Yamamoto H, Ohishi Y, Nishiyama K, Fukuhara M, Saitou T, et al. Sclerosing variant of perivascular epithelioid cell tumor in the female genital organs. Pathol Int. 2011;61:768-72 pubmed publisher
  164. Chui J, Coroneo M, Tat L, Crouch R, Wakefield D, Di Girolamo N. Ophthalmic pterygium: a stem cell disorder with premalignant features. Am J Pathol. 2011;178:817-27 pubmed publisher
  165. Qi H, Zheng X, Yuan X, Pflugfelder S, Li D. Potential localization of putative stem/progenitor cells in human bulbar conjunctival epithelium. J Cell Physiol. 2010;225:180-5 pubmed publisher
  166. Shirasaki H, Kanaizumi E, Himi T. Immunohistochemical localization of the bradykinin B1 and B2 receptors in human nasal mucosa. Mediators Inflamm. 2009;2009:102406 pubmed publisher
  167. Gil da Costa R, Santos M, Amorim I, Lopes C, Pereira P, Faustino A. An immunohistochemical study of feline endometrial adenocarcinoma. J Comp Pathol. 2009;140:254-9 pubmed publisher
  168. Rhee K, Wu S, Wu X, Huso D, Karim B, Franco A, et al. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect Immun. 2009;77:1708-18 pubmed publisher
  169. Rodriguez F, Scheithauer B, Giannini C, Bryant S, Jenkins R. Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study. Cancer. 2008;113:2779-89 pubmed publisher
  170. Lu S, Yu G, Zhu Y, Archer M. Cyclooxygenase-2 overexpression in MCF-10F human breast epithelial cells inhibits proliferation, apoptosis and differentiation, and causes partial transformation. Int J Cancer. 2005;116:847-52 pubmed
  171. Gilbert S, Loranger A, Marceau N. Keratins modulate c-Flip/extracellular signal-regulated kinase 1 and 2 antiapoptotic signaling in simple epithelial cells. Mol Cell Biol. 2004;24:7072-81 pubmed
  172. Song S, Park S, Kim S, Suh Y. Oncocytic adrenocortical carcinomas: a pathological and immunohistochemical study of four cases in comparison with conventional adrenocortical carcinomas. Pathol Int. 2004;54:603-10 pubmed
  173. Kokenyesi R, Murray K, Benshushan A, Huntley E, Kao M. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression. Gynecol Oncol. 2003;89:60-72 pubmed